Clinical Trials Browser

OTHER × Carcinoma, Lobular × Magnetic Resonance Spectroscopy × Clear all

NCT05919108 2025-09-09

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

Phase 2 Recruiting

Carcinoma, Lobular

NCT04750473 2025-01-17

Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer

Phase 1 Completed

20 enrolled 7 charts

Carcinoma, Lobular